Market Overview:
The global sivelestat sodium market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of inflammatory diseases and the rising demand for elastase inhibitors. The global sivelestat sodium market is segmented on the basis of type, application, and region. On the basis of type, it is divided into 10mg and 50mg segments. The 10mg segment is expected to account for a larger share of the market than the 50mg segment during the forecast period. On the basis of application, it is classified into anti-inflammatory disease and elastase inhibitor segments.
Product Definition:
Sivelestat Sodium is a drug that inhibits the enzyme neutrophil elastase. It is used to prevent or treat tissue damage caused by neutrophils, which are white blood cells that help fight infection. Sivelestat Sodium can improve lung function and reduce the need for mechanical ventilation in people with acute respiratory distress syndrome (ARDS).
10mg:
Sivelestat Sodium is used for the treatment of hereditary angioedema which is a rare life-threatening disease. The condition may occur due to some genetic mutation and/or due to drug or food intake. It's common symptoms are swelling of the face, legs, arms and other body parts along with itching sensation in the skin.
50mg:
Sivextro is used to treat high blood pressure and heart failure. It works by improving the ability of your body to metabolize fats and proteins, which helps reduce the amount of fat in your bloodstream. Sivextro may also help reduce cholesterol levels in the body.
Application Insights:
The global sivelestat sodium market is categorized based on the application as anti-inflammatory disease and elastase inhibitor. The anti-inflammatory disease segment dominated the overall industry in terms of revenue in 2017, owing to increasing prevalence of chronic diseases such as arthritis and osteoarthritis. According to WHO, around 50 million people suffer from arthritis every year globally. In North America, around 20 million individuals are affected by this condition while about 10% of population across Europe suffers from it. Thus, rising number of patients suffering from chronic conditions increases demand for analgesic drugs which is likely to propel growth over the forecast period.
Elastase inhibitor segment is expected to grow at a lucrative rate during the study period due largelyto its ability not only restrain but also reverse tissue degradation caused by elastin degradation products such as matrix metalloproteinases (MMPs) and collagenases (CTAs).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period, owing to increasing prevalence of chronic diseases such as cardiovascular disease, arthritis and cancer among others that are associated with inflammation. In addition, growing awareness regarding health benefits of sodium sivelestat is anticipated to propel product demand in this region over the forecast period.
Asia Pacific is expected to be one of fastest-growing regions during the forecast years due to rising disposable income coupled with expanding healthcare infrastructure especially in countries such as China and India which are major consumers for this product globally.
Growth Factors:
- Increasing incidence of chronic diseases such as cancer, diabetes, and heart diseases is expected to drive the demand for Sivelestat Sodium over the forecast period.
- Rising geriatric population is also anticipated to fuel the growth of this market owing to increasing prevalence of age-related disorders that require Sivelestat Sodium for treatment.
- Growing awareness about benefits offered by Sivelestat Sodium is projected to boost its demand in coming years.
- Technological advancements in drug delivery systems are likely to create new opportunities for this market over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sivelestat Sodium Market Research Report
By Type
10mg, 50mg
By Application
Anti-Inflammatory Disease, Elastase Inhibitor
By Companies
Ono Pharmaceutical, Eli Lilly And Company
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Sivelestat Sodium Market Report Segments:
The global Sivelestat Sodium market is segmented on the basis of:
Types
10mg, 50mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Anti-Inflammatory Disease, Elastase Inhibitor
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ono Pharmaceutical
- Eli Lilly And Company
Highlights of The Sivelestat Sodium Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 10mg
- 50mg
- By Application:
- Anti-Inflammatory Disease
- Elastase Inhibitor
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sivelestat Sodium Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sivelestat Sodium is a medication used to lower blood pressure. It is also known as hydrochlorothiazide.
Some of the major companies in the sivelestat sodium market are Ono Pharmaceutical, Eli Lilly And Company.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sivelestat Sodium Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sivelestat Sodium Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sivelestat Sodium Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sivelestat Sodium Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sivelestat Sodium Market Size & Forecast, 2020-2028
4.5.1 Sivelestat Sodium Market Size and Y-o-Y Growth
4.5.2 Sivelestat Sodium Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 10mg
5.2.2 50mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Anti-Inflammatory Disease
6.2.2 Elastase Inhibitor
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sivelestat Sodium Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sivelestat Sodium Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 10mg
9.6.2 50mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Anti-Inflammatory Disease
9.10.2 Elastase Inhibitor
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 10mg
10.6.2 50mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Anti-Inflammatory Disease
10.10.2 Elastase Inhibitor
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 10mg
11.6.2 50mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Anti-Inflammatory Disease
11.10.2 Elastase Inhibitor
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 10mg
12.6.2 50mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Anti-Inflammatory Disease
12.10.2 Elastase Inhibitor
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 10mg
13.6.2 50mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Anti-Inflammatory Disease
13.10.2 Elastase Inhibitor
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sivelestat Sodium Market: Competitive Dashboard
14.2 Global Sivelestat Sodium Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ono Pharmaceutical
14.3.2 Eli Lilly And Company
